Pharma Focus Asia
KP - Choose our fully recyclable blister films

Novel Elecsys Growth Differentiation Factor-15 (GDF-15) Assay Discovered for Cancer Treatment

Elecsys® GDF-15 assay discovered as a Companion Diagnostic (CDx) for the treatment of cancer. It helps in finding patients suitable for innovative treatment addressing unintentional weight loss in cancer patients.

Elecsys GDF-15 a quantitative serologic which uses the format of sandwich test for the detection of GDF-15 in human serum. This helps in identifying solid tumours for treatment with PF-06946860 in patients 18 years of age and older.

Cachexia results in metabolic disorder which arises with several chronic diseases such as cancer, heart failure, Chronic Obstructive Pulmonary Disease (COPD), and Chronic Kidney Disease (CKD). It is a major complication of cancer affecting more than half of cancer patients worldwide.

GDF-15 is associated with cachexia in cancer patients, leading to successful cachexia treatment with better outcomes globally.

U.S. Food and Drug Administration (FDA) grants Breakthrough Device Designation to Elecsys® GDF-15 assay as a Companion Diagnostic (CDx) in cancer treatment.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024